Theresa Kavanaugh is a partner in the firm’s nationally recognized Life Sciences Group. Her practice focuses on patent strategies in anticipation of company partnering, M&A, and financing events.

Dr. Kavanaugh has significant experience in developing patent strategies throughout the developmental life cycle of chemical and biologic therapeutics. Her work includes early stage patent development for discovery programs through post approval patent strategy for FDA-approved therapeutics, including FDA Orange Book listings, patent term extension and post grant patent review procedures. She has extensive technical expertise with pharmaceutical and small molecule therapeutics; protein, antisense and other biologic therapies; diagnostic and drug discovery platform technologies, including biomarker and microbiome modulator technology; polymer chemistry; drug delivery and extended release formulations; materials science; and chemical process technologies.